A detailed history of Callan Family Office, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Callan Family Office, LLC holds 32,507 shares of BSX stock, worth $3.34 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
32,507
Previous 28,397 14.47%
Holding current value
$3.34 Million
Previous $3.05 Billion 4.05%
% of portfolio
0.1%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

BUY
$97.03 - $108.14 $398,793 - $444,455
4,110 Added 14.47%
32,507 $3.17 Billion
Q2 2025

Jul 24, 2025

BUY
$89.7 - $107.41 $1.9 Million - $2.28 Million
21,203 Added 294.73%
28,397 $3.05 Billion
Q1 2025

May 12, 2025

SELL
$89.38 - $106.18 $125,489 - $149,076
-1,404 Reduced 16.33%
7,194 $726 Million
Q4 2024

Feb 06, 2025

BUY
$83.62 - $91.5 $718,964 - $786,717
8,598 New
8,598 $768 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Callan Family Office, LLC Portfolio

Follow Callan Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Callan Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callan Family Office, LLC with notifications on news.